We aimed to put development assistance for health for COVID-19 in the context of broader trends in global health financing, and to estimate total health spending from 1995 to 2050 and development assistance for COVID-19 in 2020.
Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national levels.
We aimed to measure the global, regional, and national incidence, prevalence, and years lived with disability (YLDs) of fractures from 1990 to 2019.
We aimed to estimate the global and regional burden due to non-optimal temperature exposure.
How did health care spending vary by race and ethnicity groups in the US from 2002 through 2016?
To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 findings for all-cause mortality and cause-specific mortality in children younger than 5 years of age, with multiple scenarios for child mortality in 2030 that include the consideration of potential effects of COVID-19, and a novel framework for quantifying optimal child survival.
We aimed to provide global, regional, and national estimates of the burden of tracheal, bronchus, and lung cancer and larynx cancer and their attributable risks from 1990 to 2019.
We estimate primary healthcare (PHC) expenditure for each low-income and middle-income country between 2000 and 2017 and test which health outputs and outcomes were associated with PHC expenditure.
We measured the associations that democracy has with universal health coverage and government health spending in 170 countries during the period 1990–2019.
This research aims to provide policymakers and researchers with a single repository of available national health expenditures by healthcare functions (ie, services) and providers of such services.
The COVID-19 pandemic and efforts to reduce SARS-CoV-2 transmission substantially affected health services worldwide. To better understand the impact of the pandemic on childhood routine immunisation, we estimated disruptions in vaccine coverage associated with the pandemic in 2020, globally and by Global Burden of Disease (GBD) super-region.
Drawing from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2020, Release 1, we did a systematic analysis of global, regional, and national vaccine coverage trends using a statistical framework, by vaccine and over time.
Does personal health care access and quality vary across ages among high-income countries and US states, and does any observed variation associate with insurance coverage?
We aimed to estimate the total reductions in under-5 mortality that are associated with increased maternal and paternal education, during distinct age intervals.
This study utilizes the most recent data available to provide an updated comparison of available data sources on government spending on immunization.
With an excess of COVID-19 vaccines in high-income settings, leaders of those countries should act on their promises to send surplus doses to countries where vaccines remain scarce.
Here we present a geospatial analysis of EBF prevalence estimates from 2000 to 2018 across 94 LMICs mapped to policy-relevant administrative units (for example, districts), quantify subnational inequalities and their changes over time, and estimate probabilities of meeting the World Health Organization’s Global Nutrition Target (WHO GNT) of ≥70% EBF prevalence by 2030.
We aimed to assess HIV incidence and HIV mortality for all second-level administrative units across sub-Saharan Africa.
The study models two indicators: prevalence of current smoking tobacco use among young adults aged 15-24 years, and the age at which current smokers aged 20-54 years in 2019 began smoking regularly.
We estimated prevalence of chewing tobacco use with a modelling strategy that used information on multiple types of smokeless tobacco products.
We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019.
This study aims to estimate health care systems' value in treating major illnesses for each US state and identify system characteristics associated with value.
Per this study, uncorrectable visual acuity loss and blindness are even larger drivers of health burden in the US than was previously known.
We analyzed California’s racial/ethnic disparities in COVID-19 exposure risks, testing rates, test positivity, and case rates through October 2020.
This analysis introduces a publicly available evaluation framework for assessing the predictive validity of COVID-19 mortality forecasts.